Product information
From Health Canada
Current status:
Marketed
Current status date:
2018-08-22
Original market date: See footnote 1
2013-12-13
Product name:
JAMP-PYRANTEL PAMOATE
DIN:
02380617 Electronic product monograph is not available
Company:
JAMP PHARMA CORPORATION
1310 Rue Nobel
Boucherville
Quebec
Canada
J4B 5H3
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
08:08.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
P02CC01 PYRANTEL
Active ingredient group (AIG) number:See footnote5
0108709003
Active ingredient(s) | Strength |
---|---|
PYRANTEL (PYRANTEL PAMOATE) | 125 MG |